AI billing claims raise U.S. healthcare costs

Blue Cross Blue Shield Association says hospitals’ use of AI in claims added $942 million over two years, fueling a wider dispute over coding and payments.

Hospitals’ use of AI in insurance claims is adding to U.S. healthcare spending, according to a new analysis from the Blue Cross Blue Shield Association. The group said the practice led to an extra $942 million in costs over a two-year period. The claim is drawing attention because it links AI not just to paperwork, but to the amount of care billed and paid for. For patients, insurers and hospitals, that lands in an area where disputes are already common.

BCBSA says coding grew more complex without changes in care

BCBSA said its analysis found “a sharp increase in patients being documented as having complex conditions.” At the same time, the association argued there was a “clear disconnect between [medical] coding and treatment,” saying it saw “no evidence of corresponding change in care delivered.”

The concern, then, is not that AI is directly treating patients or deciding medical outcomes. It is that the technology may be helping hospitals present claims in ways that make cases appear more complicated on paper, which can affect what insurers are charged.

That is why the report reaches beyond healthcare administration. AI tools are increasingly used in routine office work, and according to IT-PUB News, this case suggests automation can shape financial outcomes even when the actual treatment does not change.

The dispute is about costs as much as technology

The New York Times described the analysis as another sign that AI is contributing to higher healthcare costs. The paper also noted that fights between hospitals and insurers over treatments and payments are not new, but said AI on both sides appears to be making the situation worse.

That helps explain why the report is getting so much attention. The argument is not simply about a new tool entering healthcare. It is about whether AI is making an already tense billing system more aggressive and more expensive.

For consumers, the effect may be indirect. Higher healthcare costs can influence insurance premiums, out-of-pocket expenses and the broader pricing of medical services, even if the source text does not quantify those downstream effects.

AI is becoming part of the claims battle

The source suggests the conflict is less about medicine itself than about the paperwork around it. Hospitals submit claims, and insurers review them. AI tools may now be used to make those claims more detailed or more likely to pass scrutiny, while insurers may also be using AI in response.

Dr. Shiv Rao, founder of AI startup Abridge, said the technology could lead to “a horrible dystopic future nobody wants to live in,” with “bots fighting bots, agents fighting agents.” At the same time, he said AI might also reduce tensions and cut costs.

His comments capture the uncertainty around AI in healthcare administration. The same systems that might streamline billing could also intensify disputes if both sides use them to push harder in payment negotiations.

BCBSA says insurers are losing ground

Luke Chalker, senior vice president at BCBSA, rejected the idea that this should be seen as a balanced fight. “It’s not a war. It’s a completely one-sided blood bath,” he said, adding that insurers are on the losing side.

That language shows how strongly the association views the issue, even though the source does not include a detailed response from hospitals. It also underlines the scale of the concern for insurers, which are framing this as more than a minor accounting problem.

The broader issue is that AI may be changing the economics of healthcare administration faster than the rules around it. If algorithms help generate more complex claims, the cost of reviewing and disputing those claims could rise as well.

The report adds to the wider debate over AI in healthcare

The BCBSA analysis adds to the debate over how AI is used outside consumer apps and chatbots. In healthcare, the technology can shape back-office decisions tied to real money, even when patients never directly encounter the software.

That is part of what makes the report notable. It shows AI not only as a productivity tool or a clinical aid, but also as part of a system of incentives in which each side may try to use automation to gain an advantage.

The source does not say whether the reported cost increase will lead to new rules, restrictions or changes in how claims are reviewed. But it does show that AI’s role in healthcare is no longer just a future-facing discussion — it is already part of an active dispute over spending, billing and who ultimately pays.